Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2012

01.04.2012 | Gynecologic Oncology

What is the impact of cervical invasion on lymph node metastasis in patients with stage IIIC endometrial cancer?

verfasst von: Taner Turan, Deniz Hızlı, Saynur Sarici Yılmaz, Burcu Gundogdu, Nurettin Boran, Gokhan Tulunay, Ahmet Ozfuttu, M. Faruk Kose

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to evaluate whether the presence of cervical invasion has altered the site of lymph node (LN) metastasis in stage IIIC endometrial cancer (EC) patients.

Methods

Fourty-six patients who had systematic pelvic and para-aortic lymphadenectomy surgery for EC and staged as IIIC were included in the study. Patients with cervical invasion were defined as Group A and patients without cervical invasion were defined as Group B. The groups were compared according to surgical-pathologic characteristics. Chi-square and Annova table test were used to examine the effect of cervical invasion on LN metastasis.

Results

The mean age of patients was 59 years (range 38–81) and tumor size was 47 mm (range 10–80). Twenty-three patients had cervical involvement (Group A) and 23 had no cervical metastasis (Group B). Groups were not different with regard to cell type, grade, depth of myometrial invasion, tumor size, adnexal involvement, peritoneal metastasis and lymphovascular space invasion. Among 46 patients obturator LN was the most involved site of LN metastasis, however, when there is cervical metastasis external iliac LN was found to be the most involved LN site. Patients without cervical invasion had 21.7% of external iliac LN metastasis while patients with cervical invasion had 60.9% of external iliac LN metastasis. Also, cervical invasion has increased the risk of pelvic LN and obturator LN involvement from 82.6 to 95.7% and 39.1 to 52.2%, respectively.

Conclusion

Cervical invasion may have an effect on lymphatic spread and change the site of metastatic LNs. Large prospective studies are needed to clarify the alteration of LN metastasis in cervix invaded EC patients.
Literatur
1.
Zurück zum Zitat Announcements: FIGO (the International Federation of Obstetricians and Gynecologists) stages: 1988 revision. Gynecol Oncol 1989; 35: 125–126 Announcements: FIGO (the International Federation of Obstetricians and Gynecologists) stages: 1988 revision. Gynecol Oncol 1989; 35: 125–126
2.
Zurück zum Zitat Creasman W (2009) Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 105:109PubMedCrossRef Creasman W (2009) Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 105:109PubMedCrossRef
3.
Zurück zum Zitat Watanabe Y, Aoki D, Kitagawa R et al (2007) Status of surgical treatment procedures for endometrial cancer in Japan: results of a Japanese Gynecologic Oncology Group survey. Gynecol Oncol 105:325–328PubMedCrossRef Watanabe Y, Aoki D, Kitagawa R et al (2007) Status of surgical treatment procedures for endometrial cancer in Japan: results of a Japanese Gynecologic Oncology Group survey. Gynecol Oncol 105:325–328PubMedCrossRef
4.
Zurück zum Zitat Barnes MN, Kilgore LC (2000) Complete surgical staging of early endometrial adenocarcinoma: optimizing patient outcomes. Semin Radiat Oncol 10:3–7PubMedCrossRef Barnes MN, Kilgore LC (2000) Complete surgical staging of early endometrial adenocarcinoma: optimizing patient outcomes. Semin Radiat Oncol 10:3–7PubMedCrossRef
5.
Zurück zum Zitat Frumovitz M, Escobar P, Ramirez PT (2011) Minimally invasive surgical approaches for patients with endometrial cancer. Clin Obstet Gynecol 54:226–234PubMedCrossRef Frumovitz M, Escobar P, Ramirez PT (2011) Minimally invasive surgical approaches for patients with endometrial cancer. Clin Obstet Gynecol 54:226–234PubMedCrossRef
6.
Zurück zum Zitat Mariani A, Webb MJ, Galli L et al (2000) Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol 76:348–356PubMedCrossRef Mariani A, Webb MJ, Galli L et al (2000) Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol 76:348–356PubMedCrossRef
7.
Zurück zum Zitat Creasman WT, Morrow CP, Bundy BN et al (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer 60:2035–2041PubMedCrossRef Creasman WT, Morrow CP, Bundy BN et al (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer 60:2035–2041PubMedCrossRef
8.
Zurück zum Zitat Karube Y, Fujimoto T et al (2010) Histopathological prognostic factors predicting para-aortic lymph node metastasis in patients with endometrioid uterine cancer. Gynecol Oncol 118:151–154PubMedCrossRef Karube Y, Fujimoto T et al (2010) Histopathological prognostic factors predicting para-aortic lymph node metastasis in patients with endometrioid uterine cancer. Gynecol Oncol 118:151–154PubMedCrossRef
9.
Zurück zum Zitat Nomura H, Aoki D et al (2006) Analysis of clinicopathologic factors predicting para-aortic lymph node metastasis in endometrial cancer. Int J Gynecol Cancer 16:799–804PubMedCrossRef Nomura H, Aoki D et al (2006) Analysis of clinicopathologic factors predicting para-aortic lymph node metastasis in endometrial cancer. Int J Gynecol Cancer 16:799–804PubMedCrossRef
10.
Zurück zum Zitat Yaegashi N, Ito K, Niikura H (2007) Lymphadenectomy for endometrial cancer: is paraaortic lymphadenectomy necessary? Int J Clin Oncol 12:176–180PubMedCrossRef Yaegashi N, Ito K, Niikura H (2007) Lymphadenectomy for endometrial cancer: is paraaortic lymphadenectomy necessary? Int J Clin Oncol 12:176–180PubMedCrossRef
11.
Zurück zum Zitat Mariani A, Keeney GL et al (2004) Endometrial carcinoma: paraaortic dissemination. Gynecol Oncol 92:833–838PubMedCrossRef Mariani A, Keeney GL et al (2004) Endometrial carcinoma: paraaortic dissemination. Gynecol Oncol 92:833–838PubMedCrossRef
12.
Zurück zum Zitat Morrow CP, Bundy BN, Kurman RJ et al (1991) Relationship between surgical–pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40:55–65PubMedCrossRef Morrow CP, Bundy BN, Kurman RJ et al (1991) Relationship between surgical–pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40:55–65PubMedCrossRef
13.
Zurück zum Zitat Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics, 2001. CA Cancer J Clin 51:15–36PubMedCrossRef Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics, 2001. CA Cancer J Clin 51:15–36PubMedCrossRef
14.
Zurück zum Zitat Petersen F (ed) (1991) Annual report of the results of treatment in gynecologic cancer, vol 20. Elsevier, Stockholm Petersen F (ed) (1991) Annual report of the results of treatment in gynecologic cancer, vol 20. Elsevier, Stockholm
15.
Zurück zum Zitat Boente MP, Orandi YA, Yordan EL et al (1995) Recurrence patterns and complications in endometrial adenocarcinoma with cervical involvement. Ann Surg Oncol 2:138–144PubMedCrossRef Boente MP, Orandi YA, Yordan EL et al (1995) Recurrence patterns and complications in endometrial adenocarcinoma with cervical involvement. Ann Surg Oncol 2:138–144PubMedCrossRef
16.
Zurück zum Zitat Sakuragi N, Satoh C, Takeda N et al (1999) Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer 85:1547–1554PubMedCrossRef Sakuragi N, Satoh C, Takeda N et al (1999) Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer 85:1547–1554PubMedCrossRef
17.
Zurück zum Zitat Buchsbaum HJ (1979) Extrapelvic lymph node metastases in cervical carcinoma. Am J Obstet Gynecol 133:814–824PubMed Buchsbaum HJ (1979) Extrapelvic lymph node metastases in cervical carcinoma. Am J Obstet Gynecol 133:814–824PubMed
18.
Zurück zum Zitat Pelosi E, Arena V, Baudino B et al (2003) Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early stage endometrial cancer. Nucl Med Commun 24:971–975PubMedCrossRef Pelosi E, Arena V, Baudino B et al (2003) Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early stage endometrial cancer. Nucl Med Commun 24:971–975PubMedCrossRef
19.
Zurück zum Zitat Niikura H, Okamura C, Utsunomiya H et al (2004) Sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol 92:669–674PubMedCrossRef Niikura H, Okamura C, Utsunomiya H et al (2004) Sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol 92:669–674PubMedCrossRef
20.
Zurück zum Zitat Lelievre L, Camatte S, Le Frere-Belda M et al (2004) Sentinel lymph node biopsy in cervix and corpus uteri cancers. Int J Gynecol Cancer 14:271–278PubMedCrossRef Lelievre L, Camatte S, Le Frere-Belda M et al (2004) Sentinel lymph node biopsy in cervix and corpus uteri cancers. Int J Gynecol Cancer 14:271–278PubMedCrossRef
21.
Zurück zum Zitat Altgassen C, Pagenstecher J, Hornung D et al (2007) A new approach to label sentinel nodes in endometrial cancer. Gynecol Oncol 105:457–461PubMedCrossRef Altgassen C, Pagenstecher J, Hornung D et al (2007) A new approach to label sentinel nodes in endometrial cancer. Gynecol Oncol 105:457–461PubMedCrossRef
22.
Zurück zum Zitat Frumovitz M, Bodurka DC, Broaddus RR et al (2007) Lymphatic mapping and sentinel node biopsy inwomenwith high-risk endometrial cancer. Gynecol Oncol 104:100–103PubMedCrossRef Frumovitz M, Bodurka DC, Broaddus RR et al (2007) Lymphatic mapping and sentinel node biopsy inwomenwith high-risk endometrial cancer. Gynecol Oncol 104:100–103PubMedCrossRef
23.
Zurück zum Zitat Mariani A, Webb MJ, Keeney GL et al (2001) Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical ınvolvement. Gynecol Oncol 83:72–80PubMedCrossRef Mariani A, Webb MJ, Keeney GL et al (2001) Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical ınvolvement. Gynecol Oncol 83:72–80PubMedCrossRef
24.
Zurück zum Zitat Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, Podratz KC (2008) Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 109:11–18PubMedCrossRef Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, Podratz KC (2008) Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 109:11–18PubMedCrossRef
25.
Zurück zum Zitat Watanabe Y, Satou T, Nakai H et al (2010) Evaluation of parametrial spread in endometrial carcinoma. Obstet Gynecol 116:1027–1034PubMedCrossRef Watanabe Y, Satou T, Nakai H et al (2010) Evaluation of parametrial spread in endometrial carcinoma. Obstet Gynecol 116:1027–1034PubMedCrossRef
26.
Zurück zum Zitat Pristauz G, Winter R, Fischerauer E et al (2009) Can routine gynecologic examination contribute to the diagnosis of cervical involvement by primary endometrial cancer? Eur J Gynaecol Oncol 30:497–499PubMed Pristauz G, Winter R, Fischerauer E et al (2009) Can routine gynecologic examination contribute to the diagnosis of cervical involvement by primary endometrial cancer? Eur J Gynaecol Oncol 30:497–499PubMed
27.
Zurück zum Zitat JS Ferriss, W Brix, M Henretta et al. 2009 Extent of cervical involvement in endometrial cancer as a predictor of outcome. J Clin Oncol, ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 27, No 15S (20 May Supplement), 2009 JS Ferriss, W Brix, M Henretta et al. 2009 Extent of cervical involvement in endometrial cancer as a predictor of outcome. J Clin Oncol, ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 27, No 15S (20 May Supplement), 2009
28.
Zurück zum Zitat ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmer MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomized study. Lancet 373:125–136PubMedCrossRef ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmer MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomized study. Lancet 373:125–136PubMedCrossRef
29.
Zurück zum Zitat Barton DP, Naik R, Herod J (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC Trial): a randomized study. Int J Gynecol Cancer 19:1465PubMedCrossRef Barton DP, Naik R, Herod J (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC Trial): a randomized study. Int J Gynecol Cancer 19:1465PubMedCrossRef
30.
Zurück zum Zitat Creasman WT, Mutch DE, Herzog TJ (2010) ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid? Gynecol Oncol 116:293–294PubMedCrossRef Creasman WT, Mutch DE, Herzog TJ (2010) ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid? Gynecol Oncol 116:293–294PubMedCrossRef
Metadaten
Titel
What is the impact of cervical invasion on lymph node metastasis in patients with stage IIIC endometrial cancer?
verfasst von
Taner Turan
Deniz Hızlı
Saynur Sarici Yılmaz
Burcu Gundogdu
Nurettin Boran
Gokhan Tulunay
Ahmet Ozfuttu
M. Faruk Kose
Publikationsdatum
01.04.2012
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2012
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-011-2030-7

Weitere Artikel der Ausgabe 4/2012

Archives of Gynecology and Obstetrics 4/2012 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.